Shows fda still very interested in this drug. Proves bmsn will be looking for orphan status Gives a good time table of when when they feel trials will be completed
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.